TY - JOUR
T1 - The protective effect of acadesine on ischemia-reperfusion injury
AU - Matot, Idit
AU - Jurim, Oded
PY - 2001
Y1 - 2001
N2 - The purine precursor acadesine is highly effective in preventing ischemia-reperfusion (I-R) injury of the heart and intestine. The aim of this study was to test the effect of acadesine on I-R-induced lung injury. The lobar artery of the left lower lung lobe in intact-chest, spontaneously breathing cats was occluded for 2 h (Group 1, ischemia) and reperfused for 3 h (Group 2, I-R). Animals were subjected to one of the following three protocols: acadesine administered IV 15 min before ischemia (Group 3), 15 min before reperfusion (Group 4), or 30 min after reperfusion (Group 5). Acadesine was administered at an initial dose of 2.5 mg·kg-1·min-1 for 5 min, followed by 0.5 mg·kg-1·min-1 until the end of reperfusion. Injury was assessed by histologic examination. The right lower lobe served as control. Compared with the right lower lobe, which showed no abnormal findings in any group (percentage of injured alveoli, 2% ± 1% to 4% ± 2%), the left lower lung lobe in the I-R group revealed a disrupted alveolar structure with 63% ± 9% injured alveoli. Ischemia alone did not produce alterations in alveolar structure. Acadesine significantly reduced the number of injured alveoli when given before ischemia (4% ± 1%) or reperfusion (6% ± 2%) but not when administered after reperfusion (62% ± 8%). In conclusion, acadesine, when administered before ischemia or reperfusion, can blunt I-R-induced lung injury. The mechanism underlying the protection remains to be elucidated.
AB - The purine precursor acadesine is highly effective in preventing ischemia-reperfusion (I-R) injury of the heart and intestine. The aim of this study was to test the effect of acadesine on I-R-induced lung injury. The lobar artery of the left lower lung lobe in intact-chest, spontaneously breathing cats was occluded for 2 h (Group 1, ischemia) and reperfused for 3 h (Group 2, I-R). Animals were subjected to one of the following three protocols: acadesine administered IV 15 min before ischemia (Group 3), 15 min before reperfusion (Group 4), or 30 min after reperfusion (Group 5). Acadesine was administered at an initial dose of 2.5 mg·kg-1·min-1 for 5 min, followed by 0.5 mg·kg-1·min-1 until the end of reperfusion. Injury was assessed by histologic examination. The right lower lobe served as control. Compared with the right lower lobe, which showed no abnormal findings in any group (percentage of injured alveoli, 2% ± 1% to 4% ± 2%), the left lower lung lobe in the I-R group revealed a disrupted alveolar structure with 63% ± 9% injured alveoli. Ischemia alone did not produce alterations in alveolar structure. Acadesine significantly reduced the number of injured alveoli when given before ischemia (4% ± 1%) or reperfusion (6% ± 2%) but not when administered after reperfusion (62% ± 8%). In conclusion, acadesine, when administered before ischemia or reperfusion, can blunt I-R-induced lung injury. The mechanism underlying the protection remains to be elucidated.
UR - http://www.scopus.com/inward/record.url?scp=0035120597&partnerID=8YFLogxK
U2 - 10.1213/00000539-200103000-00007
DO - 10.1213/00000539-200103000-00007
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 11226083
AN - SCOPUS:0035120597
SN - 0003-2999
VL - 92
SP - 590
EP - 595
JO - Anesthesia and Analgesia
JF - Anesthesia and Analgesia
IS - 3
ER -